Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2018 Mar 28;19(4):1011.
doi: 10.3390/ijms19041011.

Opposite Genetic Effects of CMIP Polymorphisms on the Risk of Type 2 Diabetes and Obesity: A Family-Based Study in China

Free PMC article
Clinical Trial

Opposite Genetic Effects of CMIP Polymorphisms on the Risk of Type 2 Diabetes and Obesity: A Family-Based Study in China

Yaying Cao et al. Int J Mol Sci. .
Free PMC article


C-Maf Inducing Protein (CMIP) gene polymorphisms were reported to be associated with type 2 diabetes mellitus (T2DM). Whether the association between CMIP and T2DM is mediated via obesity-related phenotypes is still unclear. We analyzed the association of CMIP rs2925979 with T2DM and a comprehensive set of obesity-related phenotypes in 1576 families ascertained from a Chinese population. These families included a total of 3444 siblings (1582 with T2DM, 963 with prediabetes, and 899 with a normal glucose level). Using multi-level mixed effects regression models, we found that each copy of CMIP rs2925979_T allele was associated with a 29% higher risk of T2DM in females (p = 9.30 × 10-4), while it was not significantly associated with T2DM in males (p = 0.705). Meanwhile, rs2925979_T allele was associated with lower levels of body mass index (BMI), waist circumference (WC), hip circumference (HC), percentage of body fat (PBF), PBF of arms, PBF of legs, and PBF of trunk in nondiabetes females (all p < 0.05). The opposite associations of rs2925979_T allele with T2DM and obesity-related phenotypes suggest that CMIP may exert independent pleiotropic effects on T2DM and obesity-related phenotypes in females.

Keywords: CMIP; family-based study; obesity; pleiotropic genetic effects; sex-specific pattern; type 2 diabetes mellitus.

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles


    1. Karaderi T., Drong A.W., Lindgren C.M. Insights into the Genetic Susceptibility to Type 2 Diabetes from Genome-Wide Association Studies of Obesity-Related Traits. Curr. Diabetes Rep. 2015;15:83. doi: 10.1007/s11892-015-0648-8. - DOI - PMC - PubMed
    1. Amerian Diabetes Association Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(Suppl. 1):S14–S80. doi: 10.2337/dc14-S014. - DOI - PubMed
    1. Frank L.K., Heraclides A., Danquah I., Bedu-Addo G., Mockenhaupt F.P., Schulze M.B. Measures of general and central obesity and risk of type 2 diabetes in a Ghanaian population. Trop. Med. Int. Health. 2013;18:141–151. doi: 10.1111/tmi.12024. - DOI - PubMed
    1. Xue H., Wang C., Li Y., Chen J., Yu L., Liu X., Li J., Cao J., Deng Y., Guo D., et al. Incidence of type 2 diabetes and number of events attributable to abdominal obesity in China: A cohort study. J. Diabetes. 2016;8:190–198. doi: 10.1111/1753-0407.12273. - DOI - PubMed
    1. Carlsson S., Ahlbom A., Lichtenstein P., Andersson T. Shared genetic influence of BMI, physical activity and type 2 diabetes: A twin study. Diabetologia. 2013;56:1031–1035. doi: 10.1007/s00125-013-2859-3. - DOI - PubMed

Publication types